04/11/2024
3:21 PM | Esperion Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:19 PM | Esperion Therapeutics (Filer)
| Form ARS | |
03/15/2024
3:30 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:32 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:33 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:34 PM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:35 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/27/2024
8:19 AM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:23 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:14 PM | CVI Investments, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
9:50 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
02/14/2024
7:42 AM | Deep Track Capital, LP (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
5:11 AM | Esperion Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
2:46 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
2:21 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
5:04 AM | Esperion Therapeutics (Filer)
| Form 424B5 | |
01/22/2024
5:10 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
4:01 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/11/2024
3:09 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
10:02 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A | |
01/03/2024
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
7:52 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:30 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
8:00 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G | |
09/21/2023
4:06 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
2:22 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023
3:17 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
08/24/2023
8:29 AM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/21/2023
3:32 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
2:31 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023
8:02 AM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2023
7:51 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
6:07 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
3:38 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
2:32 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023
5:03 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
3:45 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
2:24 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:07 PM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:08 PM | CARROLL J MARTIN (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:08 PM | Esperion Therapeutics (Issuer)
Fischer Seth H. Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Forget Nvidia, buy this A.I. Stock Now (Ad) Forget Nvidia, Microsoft or Google.
Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why?
Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture. Click here to see the details. |
06/16/2023
3:09 PM | Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:09 PM | Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
12:25 PM | BlackRock Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
05/25/2023
3:39 PM | Esperion Therapeutics (Filer)
| Form DEFA14A | |
05/17/2023
3:40 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
8:00 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:22 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
8:26 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2023
2:38 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2023
2:22 PM | Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2023
2:24 PM | Esperion Therapeutics (Subject)
Looker Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
